Devices, systems and methods for medicament delivery

Information

  • Patent Grant
  • 10314977
  • Patent Number
    10,314,977
  • Date Filed
    Wednesday, September 6, 2017
    7 years ago
  • Date Issued
    Tuesday, June 11, 2019
    5 years ago
Abstract
An apparatus includes a housing, a medicament container, an actuator, and a biasing member. The actuator is configured to move the medicament container within the housing when the actuator is moved from a first configuration to a second configuration. The actuator includes a gas container and a puncturer. When the actuator is in the first configuration, a portion of the puncturer is disposed apart from the gas container. When the actuator is in the second configuration, the portion of the puncturer is disposed within the gas container. The gas container has a longitudinal axis offset from a longitudinal axis of the medicament container. The biasing member is configured to bias the actuator toward the second configuration.
Description
BACKGROUND

Exposure, such as via ingestion, inhalation, and/or injection, to certain allergens, toxins, and/or other substances can cause profound reactions for some and/or all people and/or animals. For example, certain people are highly allergic to certain substances, such as peanuts, shellfish, particular drugs, certain proteins, bee venom, insect bites, etc. The allergic response to the exposure can lead to anaphylactic shock, which can cause a sharp drop in blood pressure, hives, and/or substantial breathing difficulties caused by severe airway constriction. As another example, inhalation of certain nerve agents can cause severe physiological trauma. Responding rapidly to such exposures can prevent injury and/or death. For example, in response to an exposure leading to anaphylactic shock, an injection of epinephrine (i.e., adrenaline) can provide substantial and/or complete relief from the reaction. As another example, injection of an antidote to a nerve agent can greatly reduce and/or eliminate the potential harm of the exposure. As yet another example, rapid injection of certain drugs, such as a beta blocker, blood thinner, nitroglycerine, antihistamines, insulin, and opioids, etc., can provide substantial relief from various dangerous medical conditions.


Thus, certain exemplary embodiments provide systems, devices, and/or methods for rapidly injecting a medicament.


SUMMARY

Certain exemplary embodiments comprise an apparatus, comprising: a compressed gas container; a plurality of vials adapted to store a liquid medicament, each vial defining a longitudinal axis, the longitudinal axes of the plurality of vials parallel and non-co-axial, the plurality of vials fluidly coupleable to an actuating portion of a contents of the gas container; and a plurality of pistons, each piston adapted to move within a corresponding vial from the plurality of vials, the plurality of pistons adapted to, in response to discharge of the actuating portion of the contents of the compressed gas container, transfer at least a portion of the liquid medicament from the plurality of vials and through a needle that is extendable into a patient. Certain exemplary embodiments comprise a method comprising a plurality of activities, comprising: discharging an actuating portion of a contents of a compressed gas container, the compressed gas container contained within an apparatus; in reaction to said discharging activity, moving a piston within a vial, the vial one of a plurality of vials contained within the apparatus, each vial adapted to store a liquid medicament, each vial defining a longitudinal axis, the longitudinal axes of the plurality of vials parallel and non-co-axial, the plurality of vials fluidly coupleable to a contents of the gas container; and transferring a liquid medicament from the vial and through a needle that is extendable into a patient.





BRIEF DESCRIPTION OF THE DRAWINGS

A wide variety of potential embodiments will be more readily understood through the following detailed description of certain exemplary embodiments, with reference to the accompanying exemplary drawings in which:



FIG. 1 is a perspective view of an exemplary embodiment of a system 1000;



FIG. 2 is a front view of an exemplary embodiment of a system 1000;



FIG. 3 is a side view of an exemplary embodiment of a system 1000;



FIG. 4 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a first operative position;



FIG. 5 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a second operative position;



FIG. 6 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a third operative position;



FIG. 7 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a fourth operative position;



FIG. 8 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a fifth operative position;



FIG. 9 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a sixth operative position;



FIG. 10 is a flowchart of an exemplary embodiment of a method 10000;



FIG. 11 is a perspective view of an exemplary embodiment of system 1000;



FIG. 12 is a perspective cross-sectional view taken along lines B-B of FIG. 11;



FIG. 13 is a perspective view of an exemplary embodiment of actuation stick 2200;



FIG. 14 is a cross-sectional view of an exemplary embodiment of gas venting mechanism 8000 taken along lines A-A of FIG. 3.





DETAILED DESCRIPTION

When the following terms are used herein, the accompanying definitions apply:

    • actuating portion—that part that puts something into action.
    • actuation lock—a device adapted to prevent actuation, such as, for example a pivotable, translatable, keyed, squeezable, and/or removable lock.
    • actuator—a mechanism that puts something into action.
    • adapted to—suitable or fit for a particular purpose.
    • apparatus—a mechanism and/or device.
    • arm—an elongated structural member, which need not be solely linear.
    • can—is capable of, in at least some embodiments.
    • channel—a conduit for one or more fluids.
    • compressed gas—a substantially pressurized substance, such as helium, nitrogen, and/or carbon dioxide, etc., in a gaseous form.
    • comprising—including but not limited to.
    • contain—to hold within.
    • contents—a contained compressed gas.
    • credit card—a card (usually plastic) that assures a seller that the person using it has a satisfactory credit rating and that the issuer will see to it that the seller receives payment for the merchandise and/or services delivered. Typically measuring in size from approximately 3 to approximately 4 inches in length, such as approximately 3.40 inches, 3.375 inches, 85 millimeters, etc., and from approximately 1.75 to approximately 2.75 inches in width, such as approximately 2.10 inches, 2.2125 inches, 2.5 inches, 55 millimeters, etc.
    • discharge—to release from confinement; to emit.
    • eject—to expel.
    • escape port—an opening for the exit of a gas.
    • expulsion pressure—a force applied over an area of a liquid, the force sufficient to expel the liquid in a predetermined manner.
    • extend—to move out and/or away from.
    • extendable—able to move out and/or away from.
    • fluid—a gas and/or liquid.
    • fluidly coupleable—able to be related via a fluid.
    • frangible—a device that is capable of being broken and/or penetrated to allow fluid to flow therethrough.
    • housing—something that covers, protects, holds, and/or supports.
    • in reaction to—responding indirectly and/or directly to.
    • indicate—to show, mark, signify, denote, evidence, evince, manifest, declare, enunciate, specify, explain, exhibit, present, reveal, disclose, and/or display.
    • indicator—a device and/or substance that indicates.
    • liquid medicament—a medicine, medication, drug, pharmaceutical, prescriptive, antidote, anti-venom, hormone, stimulant, vasodilator, anesthetic, and/or nutritional supplement in a substantially liquid form.
    • may—is allowed to, in at least some embodiments.
    • needle—a hollow, slender, sharp-pointed instrument used for injection. Includes cannulas.
    • non-co-axial—not having co-linear axes.
    • patient—a receiver of a liquid medicament, such as a human, mammal, animal, etc.
    • piston—a sliding piece which either is moved by, or moves against, fluid pressure.
    • pivotable—capable of pivoting.
    • plurality—the state of being plural and/or more than one.
    • predetermined—established in advance.
    • puncturer—a device adapted to penetrate using a substantially sharp and/or tapered point, tip, edge, or the like.
    • pusher—a device adapted to convert fluid pressure to mechanical movement.
    • retract—to pull inward.
    • reservoir—a receptacle or chamber for storing and/or directing movement of a fluid.
    • spring—an elastic device, such as a coil of wire, that regains its original shape after being compressed or extended.
    • status—a state or condition.
    • substantially—to a great extent or degree.
    • system—a collection of mechanisms, devices, data, and/or instructions, the collection designed to perform one or more specific functions.
    • tip—a terminal end.
    • transfer—to convey from one place to another.
    • translatable—capable of being transferred from one place to another and/or of being moved with respect to something else.
    • valve—a device that regulates flow through a pipe and/or through an aperture by opening, closing, and/or obstructing a port and/or passageway.
    • vent—to release from confinement.
    • vial—a closable vessel.



FIG. 1 is a perspective view, FIG. 2 is a front view, and FIG. 3 is a side view, of an exemplary embodiment of a system 1000, which can comprise a housing 1100, which, in certain operative embodiments, can comprise a handheld portion 1800 separated via an actuation guard 1200 from an actuation bar 1300. Actuation guard 1200 can prevent accident activation of system 1000. Housing 1100 can be constructed of a durable material, such as stainless steel, aluminum, polycarbonate, etc., to protect a compressed gas container, medicament, injection apparatus and/or user of system 1000. The injection apparatus can be actuated by a fluid pressure, such as pressure provided by the compressed gas, which upon completion of its actuation duties can escape housing 1100 via gas escape opening, such as via status indicator 1400.


A status of a system 1000 can be determined via status indicator 1400, which can provide a view, such as via a UV blocking, photo-sensitive, and/or translucent window, into an interior of housing 1100. Viewable through the window can be a status of medicament carried by housing 1100, a location of a needle and/or injection apparatus for the medicament, and/or an activation status of system 1000. For example, if the medicament has aged to the point of discoloration, which aging might or might not render the medication useless, harmful, etc., status indicator 1400 can allow that situation to be determined. In certain exemplary embodiments, gas can escape housing 1100 via status indicator 1400 and/or another opening in housing 1100.


Certain exemplary embodiments of system 1000 can provide a compact medicament delivery mechanism that can efficiently and/or rapidly deliver a prescribed dose. The length (L) and width (W) of system 1000 can be similar to that of a credit card, and the thickness (T) can be less than one inch. Thus, certain exemplary embodiments of system 1000 can provide a conveniently carried, easy-to-use, easy to activate drug delivery apparatus that can require little to no training to safely carry, use, and/or dispose of.


To assist a user in positioning system 1000 in a correct orientation for injection, system 1000 and/or housing 1100 can provide various tactile clues. For example, a top 1110 of housing 1100 can be rounded, and a bottom 1120 of actuation bar 1300 of housing 1100 can be flat. Other tactile clues are also possible, such as bulges, ribs, grooves, gaps, roughened surfaces, indentations, etc.



FIG. 4 is a cross-sectional view taken along lines A-A of FIG. 3 of an exemplary embodiment of a system 1000 in a first operative position. FIGS. 5, 6, 7, 8, and 9 show system 1000 of FIG. 4 in second, third, fourth, fifth, and sixth operative positions, respectively.


System 1000 can comprise a housing 1100, handheld portion 1800, actuation guard 1200, and/or actuation bar 1300. System 1000 can comprise system actuator 2000, gas reservoirs 3000, medicament actuator 4000, medicament storage assembly 5000, medicament carrier 9000, needle assembly 6000, use indicator 7000, and/or gas vent mechanism 8000, etc.


Upon removal, release, rotation, and/or relocation of actuation guard 1200, system actuator 2000 can be adapted to rapidly discharge an actuating portion of a contents of a compress gas container. For example, system actuator 2000 can comprise a compressed gas container 2400, which initially can contain a compressed gas 2500, an actuating portion of which can be released from container 2400 by penetration of a gas port 2600 via a point of a puncturer 2700. Upon removal and/or relocation of actuation guard 1200, actuation bar 1300 can be moved closer to and/or in contact with handheld portion 1800. Upon removal and/or relocation of actuation guard 1200, gas container 2400 can be brought into contact with puncturer 2700 via extension of a pre-compressed spring 2300 and/or movement of an actuation stick 2200. Thus, actuation guard 1200 can prevent accident activation of system 1000 and/or unintended discharge of an actuating portion of the contents 2500 of gas container 2400.


Once gas port 2600 has been punctured, an actuating portion of compressed gas 2500 can escape from container 2400 and flow via gas reservoirs 3000, such as gas channel 3100. The flowing gas can meet and/or apply gas pressure to medicament actuator 4000, which can comprise a pusher 4100, which can travel within a sleeve 1500 defined by walls 1520. Sleeve 1500 can be constructed of metal, stainless steel, aluminum, plastic, polycarbonate, etc. Seals 4200, such as o-rings, can resist gas leakage, such as past pusher 4100 and/or out of housing 1100. Thus, pusher 4100 can function as a piston traveling within a cylinder, although it is not necessarily required that the cross-sectional shape of sleeve 1500 be round.


Medicament actuator 4000 can interface with medicament storage assembly 5000. For example, medicament actuator 4000 can comprise a plurality of plungers 4300, each of which can be capped with a piston 4400 which can sealingly slide and/or move within a corresponding vial 5100 containing a liquid medicament 5200. For example, in response to pressure applied by an actuating portion of the contents 2500 of compressed gas container 2400, pusher 4100 can cause plungers 4300 and/or pistons 4400 to simultaneously move. The number of corresponding sets of plungers 4300, pistons 4400, and/or vials 5100 can be 2, 3, 4, 5, 6, or more. Pistons 4400 can be constructed of a resilient, durable, and/or sealing material, such as a rubber. Each plunger 4300 from the plurality of plungers can define a longitudinal axis, the longitudinal axes (e.g., axes 4310, 4320, 4330, 4340) of the plurality of plungers parallel, non-coaxial, and/or co-planar.


Each vial 5100 from the plurality of vials can be substantially cylindrical with a substantially round and/or substantially elliptical cross-sectional shape. Thus, each vial 5100 can define a longitudinal axis, the longitudinal axes of the plurality of vials parallel, non-coaxial, and/or co-planar. The longitudinal axis of each vial can be co-axial with the longitudinal axis of its corresponding plunger.


Each vial can be capped at one end with a frangible 5300, which can be burst when piston 4400 generates sufficient pressure upon medicament 5200, thereby allowing at least a portion of medicament 5200 to flow out of vial 5100 and into medicament carrier 9000. Thus, the plurality of vials can be fluidly coupleable to the actuating portion of the contents 2500 of gas container 2400.


Medicament carrier 9000 can hold each of vials 5100 and can travel within sleeve 1500. Medicament carrier 9000 can comprise a plurality of channels 9200 adapted to receive medicament 5200 as it exits its respective vial 5100, and direct medicament 5200 to a common conduit 9300. Medicament carrier 9000 can interface with needle assembly 6000 and/or use indicator 7000.


From common conduit 9300, medicament 5200 can enter needle assembly 6000, such as into a single needle 6100 via which medicament can approach needle tip 6200. As medicament actuator 4000 and/or medicament carrier 9000 are driven toward actuator bar 1300, needle tip 6200 can penetrate an end 6400 of needle sheath 6300 and exit actuator bar 1300 at needle port 1340.


Referring to FIG. 5, upon movement of actuation bar 1300 closer to handheld portion 1800, sheath seat 1330 can come in contact with sheath tip 6400, thereby causing sheath 6300 to buckle and/or crumble. As actuator bar 1300 comes in contact with handheld portion 1800, bar stop 1320 can approach medicament carrier stop 9400, while carrier spring 1600 is compressed.


Referring to FIG. 6, as at least a portion of contents 2500 of gas container 2400 escapes, it can flow through channel 3100. The gas, which can still be relatively pressurized, can begin to accumulate behind pusher 4100 to form an expanding gas chamber 3200 and to cause medicament actuator 4000, medicament storage assembly 5000, and medicament carrier 9000 to slide together within sleeve 1500. As medicament actuator 4000, medicament storage assembly 5000, and medicament carrier 9000 slide closer to actuator bar 1300, spring 1600 becomes increasingly compressed between bar stop 1320 and medicament carrier stop 9400. As medicament actuator 4000, medicament storage assembly 5000, and medicament carrier 9000 slide closer to actuator bar 1300, needle tip 6200 can extend further from actuator bar 1300 and sheath 6300 can become further compressed and/or deformed. At its ultimate extension point, needle tip 6200 can extend from housing 1100 from approximately 0.25 millimeters to approximately 20 millimeters, including all values and subranges therebetween, such as up to approximately 2 millimeters, greater than approximately 5 millimeters, from approximately 5.13 millimeters to approximately 9.98 millimeters, etc.


Referring to FIG. 7, as gas chamber 3200 continues to expand, medicament carrier 9000 can be driven until medicament carrier stop 9400 contacts actuator bar stop 1300 thereby resisting further travel of medicament carrier 9000. At that point, additional expansion of gas chamber 3200 can cause medicament actuator 4000, pusher bar 4100, plungers 4300, and/or pistons 4400 to initiate travel with respect to medicament storage assembly 5000, thereby generating an expulsion pressure in vials 5100, and/or thereby rupturing frangibles 5300 and allowing medicament 5200 to enter medicament carrier 9000, and begin flowing through medicament channels 9200, medicament conduit 9300, needle 6100, and/or out needle tip 6200 and into a patient. Alternatively, frangibles 5300 can be replaced and/or augmented by a frangible located at or near where medicament conduit 9300 couples to needle 6100. Frangibles 5300 can be constructed of a thin, taught, resilient, durable, and/or sealing material potentially having a predetermined yield strength, such as a rubber, such as chromo butyl rubber, and/or of a relatively brittle material potentially having a predetermined yield strength, such as ceramic, certain plastics, such as polystyrene, etc.


As medicament carrier stop 9400 contacts actuator bar stop 1300, medicament carrier hooks 9600 can engage with engagement receivers 7100 in use indicator 7000.


Referring to FIG. 8, as gas chamber 3200 continues to expand, medicament actuator 4000, pusher bar 4100, plungers 4300, and/or pistons 4400 can continue moving until they complete their travel within medicament storage assembly 5000, thereby expelling a predetermined dose of medicament 5200 from vials 5100, out of needle assembly 6000, external to housing 1100, and/or into the patient. As gas chamber 3200 reaches its maximum size, medicament actuator 4000, pusher bar 4100, plungers 4300, and/or pistons 4400 can continue moving until they complete their travel with respect to medicament carrier 9000, thereby causing gas release actuator 9700 to engage with gas release valve 8200. Engagement of gas release actuator 9700 with gas release valve 8200 can cause within gas chamber 3200 to exit gas chamber 3200, discharge away from pistons 4400, and/or exhaust from system 1000 and/or housing 1100, such as via status indicator 1400 and/or a gas escape port located on housing 1100).


Referring to FIG. 8 and FIG. 9, as sufficient gas is vented from gas chamber 3200, the pressure applied by the gas in gas chamber 3200 can decrease until the force applied by the gas on medicament actuator 4000 is less than the force of compressed spring 1600. Thus, spring(s) 1600 can begin to expand, thereby moving medicament carrier 9000, vial assembly 5000, and medicament actuator 4000 away from actuator bar 1300 and helping to exhaust gas from gas chamber 3200. As medicament carrier 9000 moves, use indicator 7000 can travel with it, due to the engaged relationship of medicament carrier hooks 9600 and engagement receivers 7100 and/or engagement catches 7200 in use indicator 7000. As use indicator 7000 moves away from actuation bar 1300, sheath 6300 can travel with it, thereby creating a gap between sheath tip 6400 and needle port 1340, and thereby exposing a previously non-visible colored portion 1350 of actuation bar 1300 and/or providing an indication that system 1000 has been used (and likely substantially exhausted of its medicament), thereby discouraging any further attempts to use system 1000.


As medicament carrier 9000 moves away from actuator bar 1300, needle 6100 can retract into sheath 6300 which un-buckles and/or un-deforms towards its original shape. Eventually, needle 6100 can retract completely within the boundaries of housing 1100, thereby tending to prevent accidental needle sticks after the initial injection and/or potentially reducing and/or eliminating a sharps hazard.


In certain exemplary embodiments, system actuator 2000 can comprise a finger triggered, twistable, pivotable, and/or lever-operated mechanism. For example, system actuator 2000 can comprise a twistable handle that can screw into gas port 2600. In certain exemplary embodiments, system actuator 2000 can be a finger trigger located on a side of the housing.



FIG. 10 is a flowchart of an exemplary embodiment of a method 10000 for operating a medicament delivery apparatus. At activity 10100, an actuation lock for the apparatus is released. At activity 10200, an actuating portion of the contents of a compressed gas container are released. At activity 10300, via pressure provided by the released gas, a needle is extended from the apparatus. At activity 10400, via pressure provided by the released gas, a piston applies pressure to a medicament stored in one of a plurality of vials. At activity 10500, a frangible containing the medicament in the vial is burst. At activity 10600, the medicament flows from the vial, through the needle, and into a patient. At activity 10700, once a predetermined dose is expelled and/or injected, the needle is withdrawn from the patient and/or retracted into the pre-use bounds of the apparatus. At activity 10800, the apparatus is rendered unusable for additional injections and/or indicated as previously utilized.



FIG. 11 is a perspective view of an exemplary embodiment of system 1000, showing actuation guard 1200 removed from housing 1100, so that actuation guard 1200 no longer separates actuator bar 1300 from handheld portion 1800. Actuation guard 1200 can comprise a grippable portion 1220 that can be gripped by a user to pull actuation guard 1200 away from housing 1100, thereby allowing system 1000 to be activated, such as via slapping actuator bar 1300 against a thigh of the user. Actuation guard 1200 can comprise an actuation stick separator portion 1240, that can keep separate actuation stick prongs 2240 when actuation guard 1200 is installed on housing 1100. Actuation guard 1200 can comprise a guard portion 1260 that can separate actuator bar 1300 from handheld portion 1800 when system 1000 is not in use and/or when system 1000 has not been used.



FIG. 12 is a perspective cross-sectional view taken along lines B-B of FIG. 11, and FIG. 13 is a perspective view of an exemplary embodiment of actuation stick 2200. Referring to FIGS. 12 and 13, system 1000 can comprise housing 1100, actuation bar 1300, and system actuator 2000, which can comprise prong squeezer 1390, actuation stick 2200, prong retainer 2100, spring 2300, upper spring retainer 2260, gas container 2400, gas port 2600, and/or puncturer 2700. When actuation bar 1300 is pressed firmly against a user's body, such as via slapping housing actuation bar against the user's thigh, buttocks, and/or arm, prong squeezer 1390 can urge prong tips 2220 of prongs 2240 of actuation stick 2200 toward one another. Note that prong tips 2200 can have a triangular, wedge, angular, and/or frustro-conical shape. As prongs tips 2220 slide along the angled V-groove of prong squeezer 1390, prong catches 2230 can substantially loose contact with prong retainer 2100. This can allow compressed spring 2300 to rapidly urge actuation stick 2200 and gas container 2400 toward puncturer 2700, which can penetrate gas port 2600, thereby allowing gas to escape from gas container 2400. Although any of many different types of gas containers can be utilized, an exemplary gas container can be obtained from Leland Limited, Inc. of South Plainfield, N.J.



FIG. 14 is a cross-sectional view of an exemplary embodiment of gas venting mechanism 8000 of system 1000 taken along lines A-A of FIG. 3. System 1000 can comprise handheld portion 1800, actuator bar 1300, sleeve 1500. As pistons 4440 near the limit of their travels, medicament 5200 can be expelled along medicament path 5900, which can extend past frangible 5300, through medicament channels 9200, medicament conduit 9300, and needle 6100, and into the body of a user, such as subcutaneously, intramuscularly, and/or at a depth of from approximately 0.25 millimeters to approximately 20 millimeters, including all values and subranges therebetween, such as up to 2 millimeters, greater than 5 millimeters, etc.


As pistons 4440 near the limit of their travels, engagement of gas release actuator 9700 with gas release valve 8200 can cause compressed spring 8300 to move valve arm such that o-ring 8400 is urged away from its seat 8500. This movement can reveal a passage 8600, via which gas can exit gas chamber 3200 along gas exhaust path 8900, which can extend between sleeve inner walls 1520 and outer walls 9100 of medicament carrier 9000. Eventually, gas exhaust path 8900 can extend between handheld portion 1800 and actuator bar 1300. Likewise, an alternative embodiment of valve 8200, made of rubber or any other resilient material, can be placed across seat 8500 to provide a seal that, once gas release actuator 9700 interacts with valve 8200, allows valve 8200 to bend or flap upwards away from seat 8500, causing the gas to escape via passage 8600.


Still other embodiments will become readily apparent to those skilled in this art from reading the above-recited detailed description and drawings of certain exemplary embodiments. It should be understood that numerous variations, modifications, and additional embodiments are possible, and accordingly, all such variations, modifications, and embodiments are to be regarded as being within the spirit and scope of this application. For example, regardless of the content of any portion (e.g., title, field, background, summary, abstract, drawing figure, etc.) of this application, unless clearly specified to the contrary, there is no requirement for the inclusion in any claim herein or of any application claiming priority hereto of any particular described or illustrated activity or element, any particular sequence of such activities, or any particular interrelationship of such elements. Moreover, any activity can be repeated, any activity can be performed by multiple entities, and/or any element can be duplicated. Further, any activity or element can be excluded, the sequence of activities can vary, and/or the interrelationship of elements can vary. Accordingly, the descriptions and drawings are to be regarded as illustrative in nature, and not as restrictive. Moreover, when any number or range is described herein, unless clearly stated otherwise, that number or range is approximate. When any range is described herein, unless clearly stated otherwise, that range includes all values therein and all subranges therein. Any information in any material (e.g., a United States patent, United States patent application, book, article, etc.) that has been incorporated by reference herein, is only incorporated by reference to the extent that no conflict exists between such information and the other statements and drawings set forth herein. In the event of such conflict, including a conflict that would render invalid any claim herein or seeking priority hereto, then any such conflicting information in such incorporated by reference material is specifically not incorporated by reference herein.

Claims
  • 1. An apparatus, comprising: a housing;a medicament container disposed within the housing;an actuator coupled to an end portion of the housing, the actuator configured to move between a first actuator position and a second actuator position;a plunger having a first plunger end portion and a second plunger end portion, the first plunger end portion configured to move in response to the movement of the actuator to move the second plunger end portion within the medicament container from a first plunger position to a second plunger position;a medicament container interface disposed within the housing, the medicament container interface coupled to the medicament container and having a portion extending distally beyond a proximal end of the medicament container, the medicament container interface including an end stop surface configured to limit movement of the plunger in a distal direction, the end stop surface between the first plunger end portion and the second plunger end portion; anda stop member disposed within the housing distally from the end stop surface, the stop member configured to interfere with the medicament container interface to limit movement of the medicament container interface within the housing.
  • 2. The apparatus of claim 1, wherein the medicament container is configured to move within the housing, the apparatus further comprising: a biasing member configured to urge the medicament container in a proximal direction.
  • 3. The apparatus of claim 2, further comprising: a spring stop within the housing,the biasing member is a spring, a distal end portion of the spring engaging the spring stop.
  • 4. The apparatus of claim 1, wherein: the medicament container includes a single dose of a medicament; andthe second plunger end portion includes a resilient member configured to expel the medicament when the second plunger end portion moves from the first plunger position to the second plunger position.
  • 5. The apparatus of claim 4, wherein the medicament includes epinephrine.
  • 6. The apparatus of claim 1, wherein: the housing defines a status window; andcontents of the medicament container are viewable through the status window when the second plunger end portion is in the first plunger position.
  • 7. The apparatus of claim 6, further comprising: an indicator configured to move with the plunger within the housing between a first indicator position and a second indicator position, the indicator being viewable through the status window when the second plunger end portion is in the second plunger position and the indicator is in the second indicator position.
  • 8. The apparatus of claim 7, wherein the indicator exposes a colored portion to provide a visual indication when the indicator is in the second indicator position.
  • 9. The apparatus of claim 1, wherein the medicament container is in fluid communication with a needle, a portion of the needle being disposed through an opening defined by a distal end portion of the housing and outside of the distal end portion of the housing, the apparatus further comprising: a needle sheath covering the needle, the needle sheath configured to maintain sterility of the needle.
  • 10. The apparatus of claim 1, wherein a central portion of the plunger is configured to move within the medicament container interface when the second plunger end portion is moved within the medicament container from the first plunger position to the second plunger position, the central portion between the first plunger end portion and the second plunger end portion.
  • 11. The apparatus of claim 1, further comprising: an energy storage member configured to produce a force in response to the movement of the actuator;the energy storage member being operably coupled to the plunger such that the force is exerted on the first plunger end portion to cause the second plunger end portion to move from the first plunger position to the second plunger position.
  • 12. The apparatus of claim 11, wherein the energy storage member is configured to produce a pressurized gas, the apparatus further comprising: a valve configured to release the pressurized gas, the end stop surface of the medicament container interface configured to engage the valve after a portion of a medicament has been delivered from the medicament container.
  • 13. The apparatus of claim 1, wherein the medicament container and the medicament container interface are configured to move together within the housing, the apparatus further comprising: a biasing member configured to urge the medicament container and the medicament container interface in a proximal direction.
  • 14. The apparatus of claim 1, wherein: the medicament container includes a proximal edge that defines a proximal opening through which a portion of the plunger is disposed; anda proximal portion of the medicament container interface is outside of the medicament container between the first plunger end portion and the proximal edge of the medicament container, the end stop surface being within the proximal portion of the medicament container interface.
  • 15. An apparatus, comprising: a housing having a distal end portion defining an opening, a spring stop being within the housing;a medicament container configured to move within the housing in a distal direction from a first container position to a second container position;a needle in fluid communication with the medicament container, a portion of the needle being disposed through the opening and outside of the distal end portion of the housing;a needle sheath covering the needle, the needle sheath configured to maintain sterility of the needle;an actuator coupled to the housing, the actuator configured to move from a first actuator position to a second actuator position;a plunger having a first plunger end portion and a second plunger end portion, the first plunger end portion configured to move in the distal direction in response to the movement of the actuator to move the second plunger end portion within the medicament container from a first plunger position to a second plunger position;a spring having a distal end portion engaging the spring stop, the spring configured to urge the medicament container in a proximal direction;a medicament container interface coupled to the medicament container, the medicament container interface including an end stop surface configured to limit movement of the plunger in the distal direction; anda stop member disposed within the housing distally from the end stop surface, the stop member configured to directly contact the medicament container interface to limit movement of the medicament container interface within the housing.
  • 16. The apparatus of claim 15, wherein: the medicament container includes a dose of a medicament;the second plunger end portion is in contact with a resilient member configured to expel the medicament when the second plunger end portion moves from the first plunger position to the second plunger position; andthe spring is configured to urge the medicament container in the proximal direction when the medicament is being expelled.
  • 17. The apparatus of claim 16, wherein the medicament includes epinephrine.
  • 18. The apparatus of claim 15, wherein: the housing defines a status window; andcontents of the medicament container are viewable through the status window when the second plunger end portion is in the first plunger position.
  • 19. The apparatus of claim 18, further comprising: an indicator configured to move with the plunger within the housing between a first indicator position and a second indicator position, the indicator being viewable through the status window when the second plunger end portion is in the second plunger position and the indicator is in the second indicator position.
  • 20. The apparatus of claim 15, further comprising: a central portion of the plunger configured to move within the medicament container interface when the second plunger end portion is moved within the medicament container from the first plunger position to the second plunger position.
  • 21. The apparatus of claim 15, further comprising: an energy storage member configured to produce a force;the energy storage member being operably coupled to the plunger such that the force is exerted on the first plunger end portion to cause the plunger to move from the first plunger position to the second plunger position.
  • 22. The apparatus of claim 21, wherein the energy storage member is configured to produce a pressurized gas, the apparatus further comprising: a valve configured to release the pressurized gas, the end stop surface of the medicament container interface configured to engage the valve after a portion of a medicament has been delivered from the medicament container.
  • 23. An apparatus, comprising: a housing;a medicament container within the housing, the medicament container containing a dose of a medicament;a needle coupled to the medicament container, a portion of the needle configured to be disposed outside of a distal end portion of the housing;a needle sheath covering the needle, the needle sheath configured to maintain sterility of the needle;an actuator coupled to the housing, the actuator configured to move between a first actuator position and a second actuator position;a plunger having a first plunger end portion and a second plunger end portion, the first plunger end portion configured to move in response to the movement of the actuator to move the second plunger end portion within the medicament container from a first plunger position to a second plunger position to convey the dose of the medicament from the medicament container through the needle;a medicament container interface disposed within the housing, the medicament container interface coupled to the medicament container and having a portion extending distally beyond a proximal end of the medicament container, the medicament container interface including an end stop surface between the first plunger end portion and the second plunger end portion, the end stop surface configured to limit movement of the plunger when the second plunger end portion reaches the second plunger position, thereby limiting an amount of the medicament to be conveyed; anda stop member disposed within the housing distally from the end stop surface, the stop member configured to interfere with the medicament container interface to limit movement of the medicament container interface within the housing.
  • 24. The apparatus of claim 23, wherein the dose of the medicament is a single dose of epinephrine.
  • 25. The apparatus of claim 23, further comprising: an energy storage member configured to produce a force;the energy storage member being operably coupled to the plunger such that the force is exerted on the first plunger end portion to cause the plunger to move from the first plunger position to the second plunger position.
  • 26. The apparatus of claim 23, wherein a central portion of the plunger is configured to move within the medicament container interface when the second plunger end portion is moved within the medicament container from the first plunger position to the second plunger position.
  • 27. The apparatus of claim 23, the apparatus further comprising: a biasing member configured to urge the medicament container in a proximal direction.
  • 28. The apparatus of claim 27, wherein the biasing member is a spring, a distal end portion of the spring engaging a spring stop within the housing.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/149,425, entitled, “Devices, Systems and Methods for Medicament Delivery,” filed May 9, 2016, which is a continuation of U.S. patent application Ser. No. 14/581,693, now U.S. Pat. No. 9,352,091, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Dec. 23, 2014, which is a continuation of U.S. patent application Ser. No. 13/866,296, now U.S. Pat. No. 8,920,377, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Apr. 19, 2013, which is a continuation of U.S. patent application Ser. No. 13/353,769, now U.S. Pat. No. 8,425,462, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jan. 19, 2012, which is a continuation of U.S. patent application Ser. No. 12/794,014, now U.S. Pat. No. 8,105,281, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jun. 4, 2010, which is a continuation of U.S. patent application Ser. No. 12/138,987, now U.S. Pat. No. 7,731,690, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Jun. 13, 2008, which is a divisional of U.S. patent application Ser. No. 10/515,571, now U.S. Pat. No. 7,416,540, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Nov. 23, 2004, which is a national stage filing under 35 U.S.C. § 371 of International Patent Application No. PCT/US2004/039386, entitled “Devices, Systems and Methods for Medicament Delivery,” filed Nov. 23, 2004, each of which is incorporated herein by reference in its entirety.

US Referenced Citations (478)
Number Name Date Kind
2409656 Austin Oct 1946 A
2960087 Uytenbogaart Nov 1960 A
3055362 Uytenbogaart Sep 1962 A
3115133 Morando Dec 1963 A
3426448 Sarnoff Feb 1969 A
3563373 Paulson Feb 1971 A
3688765 Gasaway Sep 1972 A
3768472 Hodosh et al. Oct 1973 A
3795061 Sarnoff et al. Mar 1974 A
3797489 Sarnoff Mar 1974 A
3941130 Tibbs Mar 1976 A
3945379 Pritz et al. Mar 1976 A
4031889 Pike Jun 1977 A
4086062 Hach Apr 1978 A
4108177 Pistor Aug 1978 A
4124024 Schwebel et al. Nov 1978 A
4226235 Sarnoff et al. Oct 1980 A
4227528 Wardlaw Oct 1980 A
4258713 Wardlaw Mar 1981 A
4360019 Portner et al. Nov 1982 A
4378015 Wardlaw Mar 1983 A
4394863 Bartner Jul 1983 A
4424057 House Jan 1984 A
4425120 Sampson et al. Jan 1984 A
4441629 Mackal Apr 1984 A
4484910 Sarnoff Nov 1984 A
4573976 Sampson et al. Mar 1986 A
4596556 Morrow et al. Jun 1986 A
4610666 Pizzino Sep 1986 A
4617557 Gordon Oct 1986 A
4624660 Mijers et al. Nov 1986 A
4640686 Dalling et al. Feb 1987 A
4643721 Brunet Feb 1987 A
4664653 Sagstetter et al. May 1987 A
4666430 Brown et al. May 1987 A
4673657 Christian Jun 1987 A
4681567 Masters et al. Jul 1987 A
4689042 Sarnoff et al. Aug 1987 A
4693708 Wanderer et al. Sep 1987 A
4755169 Sarnoff et al. Jul 1988 A
4759527 Brown et al. Jul 1988 A
4781697 Slaughter Nov 1988 A
4782841 Lopez Nov 1988 A
4784652 Wikström Nov 1988 A
4795433 Sarnoff Jan 1989 A
4820286 van der Wal Apr 1989 A
4822340 Kamstra Apr 1989 A
4826489 Haber May 1989 A
4853521 Claeys et al. Aug 1989 A
4874382 Lindemann et al. Oct 1989 A
4894054 Miskinyar Jan 1990 A
4906235 Roberts Mar 1990 A
4915695 Koobs Apr 1990 A
4941880 Burns Jul 1990 A
4959056 Dombrowski et al. Sep 1990 A
4968302 Schluter et al. Nov 1990 A
4983164 Hook et al. Jan 1991 A
5000736 Kaufhold, Jr. et al. Mar 1991 A
5024656 Gasaway et al. Jun 1991 A
5037306 van Schoonhoven Aug 1991 A
5038023 Saliga Aug 1991 A
5041088 Ritson et al. Aug 1991 A
5042977 Bechtold et al. Aug 1991 A
5062603 Smith et al. Nov 1991 A
5064413 McKinnon et al. Nov 1991 A
5071353 van der Wal Dec 1991 A
5085642 Sarnoff et al. Feb 1992 A
5092842 Bechtold et al. Mar 1992 A
5092843 Monroe et al. Mar 1992 A
5104380 Holman et al. Apr 1992 A
5125898 Kaufhold, Jr. et al. Jun 1992 A
5167641 Schmitz Dec 1992 A
5199949 Haber et al. Apr 1993 A
5224936 Gallagher Jul 1993 A
5240146 Smedley et al. Aug 1993 A
5244465 Michel Sep 1993 A
5271527 Haber et al. Dec 1993 A
5281198 Haber et al. Jan 1994 A
5286258 Haber et al. Feb 1994 A
5295965 Wilmot Mar 1994 A
5298023 Haber et al. Mar 1994 A
5312326 Myers et al. May 1994 A
5314412 Rex May 1994 A
5318544 Drypen et al. Jun 1994 A
5335672 Bennett Aug 1994 A
5343519 Feldman Aug 1994 A
5344407 Ryan Sep 1994 A
5354284 Haber et al. Oct 1994 A
5356376 Milijasevic et al. Oct 1994 A
5358489 Wyrick Oct 1994 A
5363842 Mishelevich et al. Nov 1994 A
5380281 Tomellini et al. Jan 1995 A
5383851 McKinnon, Jr. et al. Jan 1995 A
5383864 van den Heuvel Jan 1995 A
5395345 Gross Mar 1995 A
5399163 Peterson et al. Mar 1995 A
5417660 Martin May 1995 A
5451210 Kramer et al. Sep 1995 A
5466217 Myers et al. Nov 1995 A
5478316 Bitdinger et al. Dec 1995 A
5503627 McKinnon Apr 1996 A
5514097 Knauer May 1996 A
5514135 Earle May 1996 A
5527287 Miskinyar Jun 1996 A
5540664 Wyrick Jul 1996 A
5558679 Tuttle Sep 1996 A
5567160 Massino Oct 1996 A
5568555 Shamir Oct 1996 A
5569192 van der Wal Oct 1996 A
5584815 Pawelka et al. Dec 1996 A
5615771 Hollister Apr 1997 A
5616132 Newman Apr 1997 A
5645534 Chanoch Jul 1997 A
5658259 Pearson Aug 1997 A
5665071 Wyrick Sep 1997 A
5681291 Galli Oct 1997 A
5681292 Tober et al. Oct 1997 A
5695476 Harris Dec 1997 A
5716338 Hjertman et al. Feb 1998 A
5728074 Castellano et al. Mar 1998 A
5734109 Thanscheidt Mar 1998 A
5772635 Dastur et al. Jun 1998 A
5779677 Frezza Jul 1998 A
5792190 Olson et al. Aug 1998 A
5800397 Wilson et al. Sep 1998 A
5805423 Wever et al. Sep 1998 A
5809997 Wolf Sep 1998 A
5813570 Fuchs et al. Sep 1998 A
5814020 Gross Sep 1998 A
5823346 Weiner Oct 1998 A
5832488 Eberhardt Nov 1998 A
5837546 Allen et al. Nov 1998 A
RE35986 Ritson et al. Dec 1998 E
5846089 Weiss et al. Dec 1998 A
5848990 Cirelli et al. Dec 1998 A
5852590 de la Huerga Dec 1998 A
5853292 Eggert et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5860957 Jacobsen et al. Jan 1999 A
5865795 Schiff et al. Feb 1999 A
5868713 Klippenstein Feb 1999 A
5868721 Marinacci Feb 1999 A
D407487 Greubel et al. Mar 1999 S
5876380 Manganini et al. Mar 1999 A
5925021 Castellano et al. Jul 1999 A
5928195 Malamud Jul 1999 A
5941857 Nguyen et al. Aug 1999 A
5964739 Champ Oct 1999 A
5971953 Bachynsky Oct 1999 A
6015438 Shaw Jan 2000 A
6030363 Kriesel Feb 2000 A
6039713 Botich et al. Mar 2000 A
6045534 Jacobsen et al. Apr 2000 A
6050977 Adams Apr 2000 A
6056728 von Schuckmann May 2000 A
6062901 Liu et al. May 2000 A
6063053 Castellano et al. May 2000 A
6074213 Hon Jun 2000 A
6077106 Mish Jun 2000 A
6083199 Thorley et al. Jul 2000 A
6084526 Blotky et al. Jul 2000 A
6086562 Jacobsen et al. Jul 2000 A
6096002 Landau Aug 2000 A
6099503 Stradella Aug 2000 A
6099504 Gross Aug 2000 A
6102896 Roser Aug 2000 A
6119684 Nöhl et al. Sep 2000 A
6120786 Cheikh Sep 2000 A
6149626 Rachynsky et al. Nov 2000 A
6158613 Novosel et al. Dec 2000 A
6161281 Dando et al. Dec 2000 A
6165155 Jacobsen et al. Dec 2000 A
6179812 Botich et al. Jan 2001 B1
6193695 Rippstein, Jr. Feb 2001 B1
6202642 McKinnon et al. Mar 2001 B1
6210359 Patel et al. Apr 2001 B1
6210369 Wilmot et al. Apr 2001 B1
6219587 Ahlin et al. Apr 2001 B1
6221045 Duchon et al. Apr 2001 B1
6221055 Shaw et al. Apr 2001 B1
6223936 Jeanbourquin May 2001 B1
6245046 Sibbitt Jun 2001 B1
6258063 Haar et al. Jul 2001 B1
6258068 Kirchhofer et al. Jul 2001 B1
6259654 de la Huerga Jul 2001 B1
6264629 Landau Jul 2001 B1
6270479 Bergens et al. Aug 2001 B1
6280421 Kirchhofer et al. Aug 2001 B1
6312412 Saied et al. Nov 2001 B1
6317630 Gross et al. Nov 2001 B1
6334070 Nova et al. Dec 2001 B1
6364866 Furr et al. Apr 2002 B1
6371939 Bergens et al. Apr 2002 B2
6383168 Landau et al. May 2002 B1
6387078 Gillespie, III May 2002 B1
6405912 Giannou Jun 2002 B2
6406455 Willis et al. Jun 2002 B1
6411567 Niemiec et al. Jun 2002 B1
6413236 Van Dyke Jul 2002 B1
6425897 Overes et al. Jul 2002 B2
6428517 Hochman et al. Aug 2002 B1
6428528 Sadowski Aug 2002 B2
6454746 Bydlon et al. Sep 2002 B1
6475181 Potter et al. Nov 2002 B1
6478771 Lavi et al. Nov 2002 B1
6482186 Douglas et al. Nov 2002 B1
6494863 Shaw et al. Dec 2002 B1
6500150 Gross et al. Dec 2002 B1
6514230 Munk et al. Feb 2003 B1
6529446 de la Huerga Mar 2003 B1
6530900 Daily et al. Mar 2003 B1
6530904 Edwards et al. Mar 2003 B1
6535714 Melker et al. Mar 2003 B2
6540675 Aceti et al. Apr 2003 B2
6544234 Gabriel Apr 2003 B1
6551276 Mann et al. Apr 2003 B1
6551298 Zhang Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6569123 Alchas May 2003 B2
6572584 Shaw et al. Jun 2003 B1
6574166 Niemiec Jun 2003 B2
6575939 Brunel Jun 2003 B1
RE38189 Walker et al. Jul 2003 E
6585685 Staylor et al. Jul 2003 B2
6585698 Packman et al. Jul 2003 B1
6589158 Winkler Jul 2003 B2
6595956 Gross et al. Jul 2003 B1
6597794 Cole et al. Jul 2003 B2
6599272 Hjertman et al. Jul 2003 B1
6613010 Castellano Sep 2003 B2
6616627 Willis et al. Sep 2003 B2
6633796 Pool et al. Oct 2003 B1
6641566 Douglas et al. Nov 2003 B2
6645171 Robinson et al. Nov 2003 B1
6645181 Lavi et al. Nov 2003 B1
6648850 Landau Nov 2003 B2
6656163 Marshall et al. Dec 2003 B1
6673035 Rice et al. Jan 2004 B1
6676630 Landau et al. Jan 2004 B2
6689093 Landau Feb 2004 B2
6692469 Weekes Feb 2004 B1
6702778 Hill et al. Mar 2004 B2
6706019 Parker et al. Mar 2004 B1
6707763 Osberg et al. Mar 2004 B2
6708050 Carim Mar 2004 B2
6722916 Buccinna et al. Apr 2004 B2
6723077 Pickup et al. Apr 2004 B2
6726657 Dedig et al. Apr 2004 B1
6726661 Munk et al. Apr 2004 B2
6736796 Shekalim May 2004 B2
6743635 Neel et al. Jun 2004 B2
6749437 Chan Jun 2004 B2
6752781 Landau et al. Jun 2004 B2
6764469 Broselow Jul 2004 B2
6767336 Kaplan Jul 2004 B1
6770052 Hill et al. Aug 2004 B2
6770056 Price et al. Aug 2004 B2
6783509 Landau et al. Aug 2004 B1
6786875 Barker et al. Sep 2004 B2
6793646 Giambattista et al. Sep 2004 B1
6803856 Murphy et al. Oct 2004 B1
6805686 Fathallah et al. Oct 2004 B1
6808514 Schneider et al. Oct 2004 B2
6809653 Mann et al. Oct 2004 B1
6817986 Slate et al. Nov 2004 B2
6830560 Gross Dec 2004 B1
6839304 Niemiec et al. Jan 2005 B2
6872200 Mann et al. Mar 2005 B2
6875195 Choi Apr 2005 B2
6883222 Landau Apr 2005 B2
6893420 Arnisolle May 2005 B2
6923764 Aceti et al. Aug 2005 B2
6936029 Mann et al. Aug 2005 B2
6936032 Bush, Jr. et al. Aug 2005 B1
6937150 Medema et al. Aug 2005 B2
6942646 Langley et al. Sep 2005 B2
6946299 Neel et al. Sep 2005 B2
6948492 Wermeling et al. Sep 2005 B2
6949082 Langley et al. Sep 2005 B2
6952604 DeNuzzio et al. Oct 2005 B2
6953445 Wilmot et al. Oct 2005 B2
6953693 Neel et al. Oct 2005 B2
6958691 Anderson et al. Oct 2005 B1
6959247 Neel et al. Oct 2005 B2
6961285 Niemiec et al. Nov 2005 B2
6964650 Alexandre et al. Nov 2005 B2
6969259 Pastrick et al. Nov 2005 B2
6979316 Rubin Dec 2005 B1
6979326 Mann et al. Dec 2005 B2
6985870 Martucci et al. Jan 2006 B2
6997911 Klitmose Feb 2006 B2
7014470 Vann Mar 2006 B2
7074211 Heiniger et al. Jul 2006 B1
7104972 Moller et al. Sep 2006 B2
7113101 Peterson et al. Sep 2006 B2
7116233 Zhurin Oct 2006 B2
7118553 Scherer Oct 2006 B2
7126879 Snyder Oct 2006 B2
7158011 Brue Jan 2007 B2
7241278 Moller Jul 2007 B2
7329241 Horvath et al. Feb 2008 B2
7416540 Edwards et al. Aug 2008 B2
7465294 Vladimirsky Dec 2008 B1
7500963 Westbye et al. Mar 2009 B2
7500967 Thorley et al. Mar 2009 B2
7503907 Lesch, Jr. Mar 2009 B1
7544188 Edwards et al. Jun 2009 B2
7611495 Gianturco Nov 2009 B1
7637891 Wall Dec 2009 B2
7648482 Edwards et al. Jan 2010 B2
7648483 Edwards et al. Jan 2010 B2
7654983 De La Sema Feb 2010 B2
7674246 Gillespie et al. Mar 2010 B2
7731686 Edwards et al. Jun 2010 B2
7731690 Edwards et al. Jun 2010 B2
7749194 Edwards et al. Jul 2010 B2
7758550 Bollenbach et al. Jul 2010 B2
7771397 Olson Aug 2010 B1
7806866 Hommann et al. Oct 2010 B2
7850662 Veasey et al. Dec 2010 B2
7901377 Harrison et al. Mar 2011 B1
7901384 Kleyman et al. Mar 2011 B2
7918823 Edwards et al. Apr 2011 B2
7918832 Veasey et al. Apr 2011 B2
7931614 Gonnelli et al. Apr 2011 B2
7938802 Bicknell et al. May 2011 B2
7938808 Pessin May 2011 B2
7947017 Edwards et al. May 2011 B2
8016788 Edwards et al. Sep 2011 B2
8021335 Lesch, Jr. Sep 2011 B2
8105281 Edwards et al. Jan 2012 B2
8123719 Edwards et al. Feb 2012 B2
8162886 Sadowski et al. Apr 2012 B2
8172082 Edwards et al. May 2012 B2
8221347 Toles et al. Jul 2012 B2
8251947 Kramer et al. Aug 2012 B2
8276583 Farieta et al. Oct 2012 B2
8313466 Edwards et al. Nov 2012 B2
8343130 Green Jan 2013 B2
8361029 Edwards et al. Jan 2013 B2
8425462 Edwards et al. Apr 2013 B2
8608698 Edwards et al. Dec 2013 B2
8613720 Bendek et al. Dec 2013 B2
8734392 Stadelhofer May 2014 B2
8747357 Stamp et al. Jun 2014 B2
8920367 Edwards et al. Dec 2014 B2
8920377 Edwards et al. Dec 2014 B2
8939959 Baney et al. Jan 2015 B2
9022980 Edwards et al. May 2015 B2
9056170 Edwards et al. Jun 2015 B2
9084849 Edwards et al. Jul 2015 B2
9149579 Edwards et al. Oct 2015 B2
9173999 Edwards et al. Nov 2015 B2
20010005781 Bergens et al. Jun 2001 A1
20010037087 Knauer Nov 2001 A1
20020055711 Lavi et al. May 2002 A1
20020076679 Aman Jun 2002 A1
20020079326 Fuchs Jun 2002 A1
20020095120 Larsen et al. Jul 2002 A1
20020189612 Rand Dec 2002 A1
20030028145 Duchon et al. Feb 2003 A1
20030040717 Saulenas et al. Feb 2003 A1
20030105430 Lavi Jun 2003 A1
20030106824 Wilmot et al. Jun 2003 A1
20030120222 Vaillancourt Jun 2003 A1
20030132128 Mazur Jul 2003 A1
20030233070 De La Serna et al. Dec 2003 A1
20040019326 Gilbert et al. Jan 2004 A1
20040024361 Fago et al. Feb 2004 A1
20040024367 Gilbert Feb 2004 A1
20040039336 Amark et al. Feb 2004 A1
20040039337 Letzing Feb 2004 A1
20040039368 Reilly et al. Feb 2004 A1
20040054327 Gillespie, III Mar 2004 A1
20040073169 Amisar et al. Apr 2004 A1
20040092874 Mazidji May 2004 A1
20040092875 Kochamba May 2004 A1
20040094146 Schiewe et al. May 2004 A1
20040116854 Abulhaj et al. Jun 2004 A1
20040138611 Griffiths et al. Jul 2004 A1
20040143298 Nova et al. Jul 2004 A1
20040159364 Landau et al. Aug 2004 A1
20040220524 Sadowski et al. Nov 2004 A1
20040249358 McWethy et al. Dec 2004 A1
20040267204 Brustowicz Dec 2004 A1
20050020979 Westbye Jan 2005 A1
20050027255 Lavi Feb 2005 A1
20050033234 Sadowski et al. Feb 2005 A1
20050033386 Osborn et al. Feb 2005 A1
20050049561 Hommann et al. Mar 2005 A1
20050062603 Fuerst et al. Mar 2005 A1
20050090781 Baba et al. Apr 2005 A1
20050090782 Marshall et al. Apr 2005 A1
20050101912 Faust et al. May 2005 A1
20050134433 Sweeney, II Jun 2005 A1
20050148931 Juhasz Jul 2005 A1
20050148945 Chen Jul 2005 A1
20050159705 Crawford et al. Jul 2005 A1
20050165360 Stamp Jul 2005 A1
20050171477 Rubin et al. Aug 2005 A1
20050182358 Veit et al. Aug 2005 A1
20050183982 Giewercer Aug 2005 A1
20050192530 Castellano Sep 2005 A1
20050192534 Wolbring et al. Sep 2005 A1
20050197654 Edman et al. Sep 2005 A1
20050203466 Hommann et al. Sep 2005 A1
20050222539 Gonzales et al. Oct 2005 A1
20050261742 Nova et al. Nov 2005 A1
20050267403 Landau et al. Dec 2005 A1
20050273059 Mernoe et al. Dec 2005 A1
20050277891 Sibbitt Dec 2005 A1
20060030819 Young et al. Feb 2006 A1
20060053036 Coffman et al. Mar 2006 A1
20060058848 Piraino et al. Mar 2006 A1
20060069350 Buenger et al. Mar 2006 A1
20060074519 Barker et al. Apr 2006 A1
20060111666 Hommann et al. May 2006 A1
20060111671 Klippenstein May 2006 A1
20060129089 Stamp Jun 2006 A1
20060129090 Moberg et al. Jun 2006 A1
20060173408 Wyrick Aug 2006 A1
20060184133 Pessin Aug 2006 A1
20060189938 Hommann et al. Aug 2006 A1
20060200077 Righi et al. Sep 2006 A1
20060204939 Bardsley et al. Sep 2006 A1
20060223027 Smith et al. Oct 2006 A1
20060235354 Kaal et al. Oct 2006 A1
20060247578 Arguendas et al. Nov 2006 A1
20060247579 Friedman Nov 2006 A1
20060265186 Holland et al. Nov 2006 A1
20070008113 Spoonhower et al. Jan 2007 A1
20070056585 Davies et al. Mar 2007 A1
20070074722 Giroux et al. Apr 2007 A1
20070100288 Bozeman May 2007 A1
20070129686 Daily et al. Jun 2007 A1
20070135767 Gillespie, III et al. Jun 2007 A1
20070173772 Liversidge Jul 2007 A1
20070184847 Hansen et al. Aug 2007 A1
20070210147 Morrone et al. Sep 2007 A1
20070213598 Howard et al. Sep 2007 A1
20070265568 Tsals et al. Nov 2007 A1
20080147006 Brunnberg et al. Jun 2008 A1
20080154200 Lesch Jun 2008 A1
20080171995 Vitullo et al. Jul 2008 A1
20080188798 Weber Aug 2008 A1
20080228143 Stamp Sep 2008 A1
20080255513 Kaal et al. Oct 2008 A1
20080262443 Hommann et al. Oct 2008 A1
20090005735 Wikner et al. Jan 2009 A1
20090093759 Judd et al. Apr 2009 A1
20090192486 Wilmot et al. Jul 2009 A1
20090221962 Kaal et al. Sep 2009 A1
20090240200 Heneveld et al. Sep 2009 A1
20090318361 Noera et al. Dec 2009 A1
20100049125 James et al. Feb 2010 A1
20100152659 Streit et al. Jun 2010 A1
20100160894 Julian et al. Jun 2010 A1
20100185148 Gillespie, III et al. Jul 2010 A1
20100212663 Vedrine et al. Aug 2010 A1
20110060274 Kuhn Mar 2011 A1
20110077589 Karlsson et al. Mar 2011 A1
20110201999 Cronenberg Aug 2011 A1
20110245761 Jennings et al. Oct 2011 A1
20110295215 Nielsen et al. Dec 2011 A1
20120107783 Julian et al. May 2012 A1
20120289929 Boyd et al. Nov 2012 A1
20130079718 Shang et al. Mar 2013 A1
20130317477 Edwards et al. Nov 2013 A1
20150238695 Edwards et al. Aug 2015 A1
20160015907 Edwards et al. Jan 2016 A1
20160022909 Edwards et al. Jan 2016 A1
20160045670 Edwards et al. Feb 2016 A1
20160184521 Edwards et al. Jun 2016 A1
20170290982 Edwards et al. Oct 2017 A1
20180304017 Edwards et al. Oct 2018 A1
20180304018 Blondino et al. Oct 2018 A1
20190009027 Edwards et al. Jan 2019 A1
Foreign Referenced Citations (43)
Number Date Country
2019296 Nov 1971 DE
1518575 Mar 2005 EP
1712178 Oct 2006 EP
1514210 Feb 1968 FR
2506161 Nov 1982 FR
2509615 Jan 1983 FR
2700959 Feb 1993 FR
7-37194 Nov 1995 JP
09-262288 Jul 1997 JP
WO 9104760 Apr 1991 WO
WO 9302720 Feb 1993 WO
WO 9513838 May 1995 WO
WO 9526009 Sep 1995 WO
WO 9535126 Dec 1995 WO
WO 9852632 Nov 1998 WO
WO 9910031 Mar 1999 WO
WO 2001003758 Jan 2001 WO
WO 2001024690 Apr 2001 WO
WO 2001026020 Apr 2001 WO
WO 2001088828 Nov 2001 WO
WO 2001093926 Dec 2001 WO
WO 2002083205 Oct 2002 WO
WO 2002083212 Oct 2002 WO
WO 2002100469 Dec 2002 WO
WO 2003011378 Feb 2003 WO
WO 2003013632 Feb 2003 WO
WO 2003095001 Nov 2003 WO
WO 2003097133 Nov 2003 WO
WO 2004047890 Jun 2004 WO
WO 2004047891 Jun 2004 WO
WO 2004047892 Jun 2004 WO
WO 2004047893 Jun 2004 WO
WO 2004054644 Jul 2004 WO
WO 2005050526 Jun 2005 WO
WO 2005070481 Aug 2005 WO
WO 2005077441 Aug 2005 WO
WO 2006109778 Oct 2006 WO
WO 2006125692 Nov 2006 WO
WO 2007083115 Jul 2007 WO
WO 2008005315 Jan 2008 WO
WO 2008148864 Dec 2008 WO
WO 2010033806 Mar 2010 WO
WO 2013044172 Mar 2013 WO
Non-Patent Literature Citations (36)
Entry
“Solutions for Medical Devices,” 3M Brochure, ©3M, (2006), 80-6201-3490-0, 8 pages.
Tingelstad, M., “Revolutionary Medical Technology Increases Demand for Flexible Interconnects,” [online] May 15, 2006 [retrieved on Nov. 15, 2006] Retrieved from the Internet <URL: http://www.ecnmag.com/index.asp?layout=articlePrint&ArticleID=CA6332947>, 3 pages.
“Flexible circuits / Flex circuits / Flexible Technology Ltd.,” Flexible Technology Limited [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://www.flexibletechnology.com/ >, 2 pages.
“Flexible circuits capabilities of Flexible Technology Limited,” Our Flexible Circuits Capabilities [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://www.flexibletechnology.com/Flexible circuits Capability.htm >, 2 pages.
“Flex Circuits/flexible circuits design guide,” [online] [retrieved on Aug. 28, 2006] Retrieved from the Internet <URL: http://flexiblecircuit.co.uk/Flex Circuits Design Guide.htm >, 7 pages.
“Insect Stings Auto-injector Pouches and Carry Cases,” The Insect Stings On-Line Shop, [online] [retrieved on Jan. 24, 2007] Retrieved from the Internet <URL: http://www.insectstings.co.uk/acatalog/Auto Injector Pouches.html >, 3 pages.
“Anaphylaxis Canada Product Catalogue,” Anaphylaxis Canada > Living with Anaphylaxis > Tools and Resources [online] [retrieved on Jan. 24, 2007] Retrieved from the Internet <URL: http://anaphylaxis.org/content/livingwith/product catalogue.asp >, 9 pages.
“Microfluidics Device Provides Programmed, Long-Term Drug Dosing,” nano techwire.com [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://nanotechwire.com/news.asp?nid=3141&ntid=124&pg=1 >, 3 pages.
Allan, R., “Medical Electronics: Technology Advances Will Revolutionize Healthcare,” Sep. 30, 2002 [online] [retrieved on Nov. 28 2006] Retrieved from the Internet <URL: http://www.elecdesign.com/Articles/Index.cfm?AD=1&ArticleID=2041>, 3 pages.
RFID Gazette, “Smart Labels in Healthcare,” Sep. 29, 2005 [online] [retrieved on Nov. 28, 2006] Retrieved from the Internet <URL: http://www.rfidagazeete.org/2005/09/smart labels in.html >, 2 pages.
“Merck Serono Launches easypod(R), First Electronic Growth Hormone Injection Device,” Jan. 30, 2007 [online] [retrieved on Feb. 5, 2007] Retrieved from the Internet <URL: http://www.biz.yahoo.com/prnews/070130/ukm028.html?.v=8>, 3 pages.
Scholz, O., “Drug depot in a tooth,” [online] [retrieved on Feb. 6, 2007] Retrieved from the Internet <URL: http://www.fraunhofer.de/fhg/EN/press/pi/2007/02Mediendienst22007Thema2.jsp?print=true>, 1 page.
Heartsine Technology, samaritan™ PAD Accessories [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.heartsine.com/aboutsam-accessories.htm>, 4 pages.
CliniSense Corporation, “Drug delivery devices A potentially harsh environment for drugs,” Stability [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.clinisense.com/devices.htm>, 2 pages.
CliniSense Corporation, “LifeTrack Technology A new method to detect improper storage.” Stability [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.clinisense.com/tech.htm>, 2 pages.
AED Professionals™ Brochure [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.aedprofessionals.com>, 4 pages.
Ruppar, D., “Implant Technologies Expected to Remain a Niche but Effective Method of Drug Delivery,” Drug Delivery Technology, Feb. 2007, vol. 7, No. 2 [online] [retrieved on Jun. 1, 2007] Retrieved from the Internet <URL: http://www.drugdeliverytech-.
Office Action for Canadian Patent Application No. 2,586,525, dated Aug. 17, 2010.
Examination Report for British Patent Application No. GB 0708523.6, dated Dec. 8, 2008.
Office Action for JP2007-543005, dated Feb. 1, 2010.
Examination Report for British Patent Application No. GB 0822532.8, dated Jan. 21, 2009.
Examination Report for British Patent Application No. GB 0822532.8, dated May 21, 2009.
Office Action for U.S. Appl. No. 11/562,061, dated Feb. 3, 2009.
Office Action for U.S. Appl. No. 11/566,422, dated Jul. 6, 2010.
Office Action for U.S. Appl. No. 11/566,422, dated Dec. 3, 2010.
Office Action for Japanese Patent Application No. 2009-537380, dated Jun. 15, 2012.
Office Action for U.S. Appl. No. 11/758,393, dated May 13, 2009.
Search Report and Written Opinion for International Patent Application No. PCT/US07/84891 dated Sep. 15, 2008, 7 pages.
Office Action for U.S. Appl. No. 12/138,987, dated Oct. 5, 2009.
Office Action for U.S. Appl. No. 13/090,392, dated Feb. 29, 2012.
International Search Report and Written Opinion for International Patent Application No. PCT/US06/03415, dated Jul. 13, 2006, 10 pages.
International Search Report and Written Opinion for International Patent Application No. PCT/US07/007626, dated Sep. 29, 2008.
Office Action for Canadian Patent Application No. 2,762,072, dated Mar. 14, 2016.
Third Party Observations filed in European Patent Application No. 07864490.3, mailed Aug. 22, 2016.
Office Action for U.S. Appl. No. 14/731,048, dated Oct. 19, 2016.
Office Action for U.S. Appl. No. 15/631,076, dated Apr. 8, 2019.
Related Publications (1)
Number Date Country
20180008774 A1 Jan 2018 US
Continuations (7)
Number Date Country
Parent 15149425 May 2016 US
Child 15696287 US
Parent 14581693 Dec 2014 US
Child 15149425 US
Parent 13866296 Apr 2013 US
Child 14581693 US
Parent 13353769 Jan 2012 US
Child 13866296 US
Parent 12794014 Jun 2010 US
Child 13353769 US
Parent 12138987 Jun 2008 US
Child 12794014 US
Parent 10515571 US
Child 12138987 US